Skip to main content
Updating results

Covid 19 Vaccine Rollout

  • Updated

WASHINGTON (AP) — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

  • Updated

KYIV, Ukraine (AP) — Ukraine's coronavirus infections and deaths reached all-time highs for a second straight day Friday, in a growing challenge for the country with one of Europe's lowest shares of vaccinated people.

BOISE, Idaho (AP) — With expanded access to coronavirus boosters approved and vaccinations for younger kids on the horizon, family physicians are fielding phone calls from people eager to get the shots. But this round of vaccinations is more complicated than the last — with mix-and-match possibilities between different vaccine brands, different dosage sizes and varying rules about exactly who qualifies for which booster.

  • Updated

WASHINGTON (AP) — The U.S. on Thursday donated its 200 millionth COVID-19 shot to help vaccinate the rest of the world, the White House announced. The Biden administration aims to lead a global vaccination campaign even as it rolls out boosters for domestic use, which critics say diverts doses from those who are in greater need around the world.

  • Updated

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.

  • Updated

WASHINGTON (AP) — Children ages 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician's office, local pharmacy and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorization of the Pfizer shot for elementary school youngsters in a matter of weeks.

  • Updated

JOHANNESBURG (AP) — The South African drug regulator has rejected the Russian-made coronavirus vaccine Sputnik V, citing some safety concerns the manufacturer wasn't able to answer.

  • Updated

WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.

Get up-to-the-minute news sent straight to your device.

Topics

News Alert

Breaking News